CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 142 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $112,000 | -81.3% | 13,500 | -58.3% | 0.02% | -55.8% |
| Q3 2018 | $599,000 | -76.9% | 32,385 | -71.4% | 0.04% | -77.0% |
| Q2 2018 | $2,591,000 | -13.0% | 113,345 | +8.3% | 0.19% | -16.5% |
| Q1 2018 | $2,979,000 | -28.0% | 104,706 | -46.6% | 0.22% | -26.3% |
| Q4 2017 | $4,138,000 | +39.0% | 196,032 | +19.6% | 0.30% | +49.8% |
| Q3 2017 | $2,977,000 | – | 163,852 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,877,148 | $13,853,000 | 1.46% |
| Congress Park Capital LLC | 167,811 | $1,238,000 | 1.04% |
| Perceptive Advisors | 3,253,923 | $24,014,000 | 0.65% |
| RTW INVESTMENTS, LP | 990,463 | $7,310,000 | 0.44% |
| Spark Investment Management LLC | 337,164 | $2,488,000 | 0.32% |
| Exane Asset Management | 54,065 | $399,000,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $738,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $584,000 | 0.24% |
| WELD CAPITAL MANAGEMENT LLC | 86,363 | $637,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,997 | $576,000 | 0.08% |